PanGen Biotech Inc (222110) - Total Liabilities

Latest as of September 2025: ₩2.74 Billion KRW ≈ $1.86 Million USD

Based on the latest financial reports, PanGen Biotech Inc (222110) has total liabilities worth ₩2.74 Billion KRW (≈ $1.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PanGen Biotech Inc (222110) equity growth momentum to track the company's year-over-year net asset growth rate.

PanGen Biotech Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how PanGen Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. See PanGen Biotech Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

PanGen Biotech Inc Competitors by Total Liabilities

The table below lists competitors of PanGen Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Moneyme Ltd AU:MME	Australia	AU$1.79 Billion
Kairous Acquisition Corp Ltd NASDAQ:KACL	USA	$7.09 Million
SK Innovation Co Ltd Pref KO:096775	Korea	₩72.01 Trillion
GFG Resources Inc V:GFG	Canada	CA$2.27 Million
SelfWealth Limited AU:SWF	Australia	AU$344.06 Million
Yuhan Corp Preferred KO:000105	Korea	₩936.71 Billion
AML3D Ltd AU:AL3	Australia	AU$7.53 Million
Aimflex Bhd KLSE:0209	Malaysia	RM18.32 Million

Liability Composition Analysis (2014–2024)

This chart breaks down PanGen Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 222110 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PanGen Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PanGen Biotech Inc (2014–2024)

The table below shows the annual total liabilities of PanGen Biotech Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.64 Billion ≈ $3.82 Million	-31.06%
2023-12-31	₩8.18 Billion ≈ $5.54 Million	+136.67%
2022-12-31	₩3.45 Billion ≈ $2.34 Million	-84.43%
2021-12-31	₩22.18 Billion ≈ $15.03 Million	+0.37%
2020-12-31	₩22.10 Billion ≈ $14.98 Million	+6.98%
2019-12-31	₩20.66 Billion ≈ $14.00 Million	+10.65%
2018-12-31	₩18.67 Billion ≈ $12.65 Million	+335.84%
2017-12-31	₩4.28 Billion ≈ $2.90 Million	+104.76%
2016-12-31	₩2.09 Billion ≈ $1.42 Million	-77.60%
2015-12-31	₩9.34 Billion ≈ $6.33 Million	+50.99%
2014-12-31	₩6.18 Billion ≈ $4.19 Million	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$45.36 Million

₩66.93 Billion KRW

Market Cap Rank

#22212 Global

#1358 in Korea

Share Price

₩4960.00

Change (1 day)

+1.22%

52-Week Range

₩4330.00 - ₩7340.00

All Time High

₩24450.00